Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

Breast cancer is one of the most prevalent diseases among women worldwide and is highly associated with cancer-related mortality. Of the four major molecular subtypes, HER2-positive and triple-negative breast cancer (TNBC) comprise more than 30% of all breast cancers. While the HER2-positive subtype...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ishita, Rizeq, Balsam, Vranic, Semir, Moustafa, Ala-Eddin Al, Al Farsi, Halema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554858/
https://www.ncbi.nlm.nih.gov/pubmed/32942528
http://dx.doi.org/10.3390/ijms21186750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554858/
https://www.ncbi.nlm.nih.gov/pubmed/32942528
http://dx.doi.org/10.3390/ijms21186750

Ejemplares similares